Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

32.66
Delayed Data
As of Jan 20
 -1.57 / -4.59%
Today’s Change
8.00
Today|||52-Week Range
63.73
+19.07%
Year-to-Date
5 Healthcare Stocks Poised for Maximum Gains in 2017
Jan 17 / MotleyFool.com - Paid Partner Content
Are Options Traders Betting on a Big Move in Sarepta Therapeutics (SRPT) Stock?
Jan 11 / Zacks.com - Paid Partner Content
Here's a New List of Stocks That Show Bullish or Bearish Reversal Patterns
Jan 17 / TheStreet.com - Paid Partner Content
What Sarepta Therapeutics' CEO Said That Made the Stock Soar
Jan 10 / MotleyFool.com - Paid Partner Content
Bullish and Bearish Reversals in the Market
Jan 17 / TheStreet.com - Paid Partner Content
Sarepta Opens Up About Duchenne Drug Launch, Allays Investors' Worst Fears
Jan 10 / TheStreet.com - Paid Partner Content
Is This Going To Be Sarepta Therapeutics' Year?
Jan 11 / MotleyFool.com - Paid Partner Content
3 Tempting Stocks We're Avoiding
Jan 10 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close34.23
Today’s open34.29
Day’s range32.44 - 34.67
Volume2,168,428
Average volume (3 months)3,942,300
Market cap$1.9B
Dividend yield--
Data as of 3:59pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-53.39%
Earnings growth (this year)+3.29%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)-87.16%
P/E ratioNM
Price/Sales1,302.11
Price/Book8.21

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...+0.19+0.36%
ARRYArray Biopharma Inc+0.17+1.52%
LGNDLigand Pharmaceutica...+1.92+1.90%
AGIOAgios Pharmaceutical...+0.25+0.59%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$1.23
Annual revenue (last year)$1.3M
Annual profit (last year)-$220.0M
Net profit margin-17,560.26%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive &
Medical Officer
Edward M. Kaye
Chief Financial Officer &
Senior Vice President
Sandesh Mahatme
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs